Clinical Trial

Directional PSA Versus STN DBS for TD-PD

Name: Directional PSA Versus STN DBS for TD-PD — clinical trial record (NCT07700862)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to compare the effectiveness of the deep brain stimulation in the posterior subthalamic area (PSA) versus the subthalamic nucleus (STN) using directional lead for the treatment of tremor-dominant Parkinson's disease (PD) in a randomized, double-blinded, cross-over manner.

Trial Details

NCT Number	NCT07700862
Lead Sponsor	Ruijin Hospital
Conditions	Parkinsons Disease (PD)
Enrollment	32 participants
Start Date	2026-07-01
Primary Completion	2028-12 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-14